Latin America Clinical Nutrition Market

Latin America Clinical Nutrition Market Size (2024 to 2029)

The size of the Clinical Nutrition market in Latin America was worth USD 0.85 Billion in 2023. The Latin American market is estimated to be growing at a CAGR of 5.13% from 2024 to 2029 and be worth USD 1.15 bn by 2029 from USD 0.89 bn in 2024.

Clinical nutrition products are the best options for different diseases, such as diabetes, cardiovascular diseases, cancer, and kidney diseases. Growing demand for clinical nutrition in the pediatric category is evolving as a potential prospect for the global clinical nutrition market. In addition, increasing home care usage of nutritional products is predicted to create new demand for the clinical nutrition market during the forecast period.

Factors such as high birth rate, a high number of premature births, and a rise in the number of victims of malnutrition receiving treatment are some of the essential drivers for the growth of the clinical nutrition market. In addition, some of the significant factors contributing to the growth of the clinical nutrition market include a rise in consumer awareness about health and well-being and increasing healthcare costs.

Stringent FDA regulations are restraining the growth of the market.

This research report on the Latin American clinical nutrition market has been segmented and sub-segmented into the following categories:

Latin America Clinical Nutrition Market - By Product Type: 

• Oral Nutrition
• Enteral Nutrition
• Parenteral Nutrition

Latin America Clinical Nutrition Market - By Therapeutic Areas: 

• Malabsorption
• Diarrhea
• Cancer
• Food Allergies
• Maldigestion
• Diabetes
• Short-Bowel Syndrome
• Acute Lung Injury
• Acute Respiratory Distress

Latin America Clinical Nutrition Market - By Ingredients Type: 

• Vitamins
• Minerals
• Carbohydrates
• Amino Acids

Latin America Clinical Nutrition Market - By Country: 

• Mexico
• Brazil
• Argentina
• Chile
• Rest of Latin America

Geographically, the Mexican clinical nutrition market is expected to account for the largest share of the Latin American market during the forecast period. Increasing urbanization, sedentary lifestyles, and unhealthy diets are estimated to boost the clinical nutrition market in Mexico.

The Brazilian clinical nutrition market is another promising regional market in Latin America. Improving healthcare facilities, the development of oral consumption of nutrition products are primarily accelerating the Brazilian clinical nutrition market. In addition, rising obesity levels and growing cases of chronic diseases have increased the need levels of clinical nutrition products in this country, which favors the market growth in Brazil.

There is an increased demand for organic food, nutritional, and conventional products in Argentina, actively supporting the Argentina clinical nutrition market. In addition, the government of Argentina has announced 50% of the nutrition policy budget to balance the nutrition levels in people, further anticipating the clinical nutrition market growth in this country during a food emergency.

KEY MARKET PLAYERS:

Some of the prominent companies operating in the Latin American Clinical Nutrition Market profiled in this report are Nestle Nutrition, Abbott Laboratories Inc., Gentiva Health Services Inc., Mead Johnson & Company, Kendall, Ajinomoto Co. Inc., Hospira Inc., Hero Nutritionals Inc., Lonza Ltd, Baxter International Inc., B. Braun Melsungen AG, H. J. Heinz Company, American Home Patient Inc. and Fresenius Kabi.